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Abstract: A novel bioactive glass containing therapeutic ions with enhanced biocompatibility was
designed and produced by the classical melt-quenching route. Starting from a very promising
composition (Bio_MS), which combined bioactivity and high crystallization temperature, the ratio
between some oxides was tailored to obtain a new and more reactive (in terms of dissolution rate)
bioactive glass, called BGMSN (composition in mol%: 6.1 Na2O, 31.3 CaO, 5 MgO, 10 SrO, 2.6 P2O5,
45 SiO2). The aim of this work was to produce a bioactive glass with a good biological performance,
preserving, at the same time, the high crystallization temperature achieved for Bio_MS; this is strategic
in order to avoid undesired crystalline phases during thermal treatments, which can undermine the
bioactivity and even the stability of final products. A complete characterization of the novel bioactive
glass was performed in terms of thermal, mechanical and biological properties and in vitro bioactivity.
The thermal behavior of the bioactive glass was studied by heating microscopy, differential thermal
analysis (DTA) and optical dilatometry; BGMSN showed a very high crystallization temperature
and a high sinterability parameter, thus being suitable for applications where thermal treatments are
required, such as sintered samples, coatings and scaffolds. Mechanical properties were investigated
by the micro-indentation technique. The in vitro biological properties were evaluated by means of
both direct and indirect cell tests, i.e., neutral red (NR) uptake and MTT assay, using murine long
bone osteocyte Y4 (MLO-Y4) cells: the cellular viability of BGMSN was higher compared to cellular
viability of 45S5, both in direct and indirect tests. Finally, the in vitro bioactivity test by soaking
samples in simulated body fluid (SBF) showed high dissolution rate, with a good rate of formation
of hydroxyapatite.
Keywords: bioactive glasses; strontium; magnesium; high crystallization temperature; dissolution
rate; tissue regeneration; cell culture
1. Introduction
Since the development of the 45S5 Bioglass® (45S5) by L.L. Hench [1,2], bioactive glasses
have been widely employed as biomaterials for small bone implants, orthopedic and periodontal
reconstruction, scaffolds and coatings. Bioactive glasses should exhibit biocompatibility, non-cytotoxicity,
immunogenicity and bioactivity to be suitable for the human body without causing the formation
of fibrous tissues in the area or the rejection of implant. The human body requires some elements
which are indispensable for the regulation of body fluids and acid-base balance. These elements
can be divided in macro-elements and micro-elements. Macro-elements include phosphorous (P),
Materials 2020, 13, 4600; doi:10.3390/ma13204600 www.mdpi.com/journal/materials
Materials 2020, 13, 4600 2 of 16
calcium (Ca), chlorine (Cl), sodium (Na) and potassium (K), in the quantity >100 mg/dL; micro-elements
are copper (Cu), zinc (Zn), sulphur (S) and magnesium (Mg), <100 mg/dL [3]. Ca and P are the major
constituents of bone and teeth. Calcium is utilized by organisms in muscle contraction, membrane
permeability and neuromuscular excitability, whereas phosphorous is involved in the synthesis of
phosphoproteins and phospholipids. Furthermore, silicon is a component of connective tissue and
is involved in the calcification of bones. Sodium is a main cation of extracellular fluid; it regulates
plasma volume and preserves osmotic pressure. In this regard, from the compositional aspect of
bioactive glasses, certain oxides (i.e., silicon oxide, phosphorous oxide, calcium oxide and sodium
oxide) are included in the composition to enhance tissue remodeling to its natural form when bioactive
glasses undergo dissolution. These oxides help the bond to bone formation and their dissolution
acts on osteoprogenitors cells stimulating new bone growth (i.e., Ca and Si ions have been shown to
stimulate osteoblast cell division and production of growth factors (GFs)) [2,4]. The bonding with bone
is ascribed to the formation of hydroxycarbonate apatite (HCA) [5]. Such formation is well understood
and the mechanism is widely reported in the literature [6,7]. A lot of research work has been carried out
to develop bioactive glasses with different compositions to enhance biocompatibility and bioactivity
(i.e., the ability to form a HCA layer under biological fluid contact) and to induce a specific response in
the host [8]. In recent years, many other applications of bioactive glasses outside the skeletal system
have emerged—for example, for tissue engineering (also soft tissues) and wound healing [9,10].
Typically, such applications require thermal treatments to obtain products, such as sintered parts,
scaffolds and coatings [11,12]. In this scenario, the crystallization behavior is of pivotal importance,
since it is well known that crystallization can inhibit, or at least reduce, bioactivity [2] and, in some
cases, even undermine the stability of the implant [13]. In fact, 45S5, besides creating a high-pH
environment causing cytotoxicity [14], has a high tendency to crystallize, showing a narrow sintering
window [2], which represents a limit in case of thermal treatment. Therefore, a high crystallization
temperature and low tendency to crystallize are fundamental characteristics to avoid complete or
partial crystallization phenomena.
Recently, a novel bioactive glass called Bio_MS has been developed [15] to achieve a high
crystallization temperature: Bio_MS returned very promising results in terms of thermal properties
and biological performance, showing cell adhesion, colonization and bone differentiation, being also
suitable for possible thermal treatments [15].
In this work, a novel bioactive glass named BGMSN was designed, starting from the successful
composition of Bio_MS, with the aim to improve its reactivity in terms of biological performance and
in vitro bioactivity, preserving, at the same time, high crystallization temperature. The ratio between
some oxides was tailored to obtain a new and more reactive (in terms of dissolution rate) bioactive
glass, based on the concept of network connectivity [2]. It is well known in the literature that by adding
Na2O (i.e., a network modifier) at the expense of SiO2 (i.e., network forming), the dissolution rate of
the bioactive glass increases because its network connectivity decreases [2]. As a matter of fact, a more
reactive bioactive glass—in terms of dissolution rate—with a faster release of therapeutic ions could be
particularly suitable for regenerative medicine.
The dissolution rate and consequently the rate of formation of HCA depend on the atomic structure
of the bioactive glass. It has been shown that the dissolution of SiO2 (i.e. network forming) is directly
related to the bioactivity of the bioactive glass [16]. In silica-based bioactive glasses, the connectivity of
the network depends on the SiO2 amount and on other ions that act as network modifiers. By decreasing
the SiO2 amount, which constitutes the bioactive glass network, and increasing the Na2O amount, the
dissolution rate of bioactive glass increases because the network connectivity decreases. This increase
is due to a lower SiO2 amount, which means a less-connected silica network with less bridging
oxygen bonds (BO), and a higher Na2O amount, which contributes to further decreasing the network
connectivity [2], since Na atoms break Si−O bonds to produce non-bridging oxygens (NBOs) [17].
Moreover, the glass transition temperature is reduced as the Na2O is increased and this is a reflection
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of the degree of network disruption [17,18]. A less-connected network results in faster dissolution of
bioactive glass, improving reactivity and, in turn, bioactivity [2].
Furthermore, SrO and MgO amounts were kept unchanged from the Bio_MS composition because
such oxides have been shown to further contribute to decrease the glass transition temperature Tg and
increase the crystallization temperature Tc [19–22]. Nonetheless, the incorporation of SrO and MgO
not only aims to improve thermal properties but it also aims to enhance the biological performance;
it has been reported that Sr and Mg ions improve effectiveness for bone regeneration [23–26] and cell
proliferation [27,28].
A complete and thorough characterization in terms of thermal, mechanical and biological properties
and in vitro bioactivity of the novel BGMSN was performed to assess the favorable combination
of features, i.e., high crystallization temperature and good biological performance. Differential
thermal analysis (DTA) and a heating microscope were used to determine the critical temperatures
of BGMSN (glass transition temperature, sintering temperature, onset crystallization temperature,
peak crystallization temperature and melting temperature). Moreover, optical dilatometry was
employed to determine the thermal expansion coefficient (CTE). On the other hand, mechanical
properties were assessed by micro-indentation technique to evaluate the Young’s modulus and Vickers
hardness of BGMSN.
Furthermore, in vitro bioactivity was studied by soaking samples in simulated body fluid (SBF)
solution for 1, 7 and 14 days, in terms of formation of hydroxycarbonate apatite (HCA) on the samples’
surface. Additionally, the biological performance of BGMSN was investigated by direct assay (neutral
red (NR) uptake) and indirect assay (MTT) using MLO-Y4 cells.
2. Materials and Methods
2.1. Preparation of Glass Powders
The novel composition of BGMSN is reported in Table 1. Commercial raw powders from Carlo
Erba Reagenti, Italy, namely SiO2, Ca3(PO4)2, SrCO3, MgCO3, CaCO3 and Na2CO3, were mixed in
a lab shaker for 3 h. Then, the mixed powders were melted in a Pt crucible in air to produce BGMSN
bioactive glass by a melt-quenching route as described elsewhere [29–32]. The thermal cycle to melt
BGMSN was: (a) 25 ◦C→ 1100 ◦C, rate 10 ◦C/min; (b) decarbonation step: 1100 ◦C for 2 h; (c) 1100 ◦C
→1450 ◦C, rate 10 ◦C/min; (d) 1450 ◦C for 45 min. The molten glass was quickly quenched in water
(at room temperature) to obtain a frit. Such frit was dried at 110 ◦C for 14 h and then ground to obtain
powders with final grain size <63 µm.
Table 1. Composition (in oxides mol %) of produced bioactive glass.
Oxides Na2O CaO MgO SrO P2O5 SiO2
Composition (mol%) 6.1 31.3 5 10 2.6 45
2.2. Thermal Behaviour of the Bioactive Glass
Heating microscopy (HM, Misura 3.32; Expert System Solutions, Modena, Italy), and differential
thermal analysis (DTA, Netzsch Differential Thermal Analyzer STA 429 CD, Netzsch-Gerätebau
GmbH, Selb, Germany) techniques were employed to determine the critical temperatures of BGMSN.
The heating microscope permits (i) to investigate the critical temperatures for the optimization of
manufacturing processes, identifying the sintering temperature (Ts), softening temperature (Td) and
melting temperature (Tm) and (ii) to study the sintering behavior of the glass. On the other hand,
during DTA analysis, 30 mg of glass powder was heated from room temperature to 1400 ◦C (rate
10 ◦C/min) to obtain the glass transition temperature (Tg), the onset crystallization temperature (Tc_onset)
and the peak crystallization temperature (Tc).
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Moreover, optical dilatometry (OD) was performed (using Misura 3.32, Expert System Solutions,
Modena, Italy) to determine the thermal expansion coefficient (CTE) and to give precious information
regarding the sintering kinetics, since sintering is usually accompanied by high specimen shrinkages.
A 5 × 5 × 15 mm3 bar was heated from 25 ◦C to 730 ◦C at 5 ◦C/min.
The sintering attitude of BGMSN was also evaluated by means of the sinterability parameter
(Sc) [33]. Sc expresses the competing mechanisms between crystallization and sintering when the glass
powders are heated and it is calculated as follows [33]:
Sc = Tc_onset − Ts
Finally, sintered disks were fabricated by pressing BGMSN powders with some drops of ethanol.
Consequently, the disks were sintered at 711 ◦C (i.e., the determined sintering temperature Ts) for 3 h.
Additionally, 45S5 disks were also prepared following the same procedure to be used as reference
during biological tests.
2.3. Microstructural Characterization
Environmental scanning electron microscopy (ESEM) was used to study the microstructure of
the sintered disks (Quanta 2000, FEI Co., Eindhoven, The Netherlands). ESEM was utilized before
and after immersion in simulated body fluid (SBF) solution (Section 2.5) to evaluate the formation of
hydroxycarbonate apatite (HCA) on the samples’ surface. Furthermore, a disk previously sintered
at 711 ◦C and subsequently crushed in powder was investigated by X-ray diffractometry (XRD,
Philips PW3710, Almelo, The Netherlands), to confirm that BGMSN samples remained amorphous
despite the thermal treatment. Data collection was performed using a Cu-kα X-ray line by a 2θ scan
method in the range of 10–90◦ with steps of 0.02◦ (6 s each step).
2.4. Mechanical Testing
Mechanical properties were studied by using the micro-indentation technique. Open Platform
equipment (CSM Instruments, Peseux, Switzerland) was used to investigate both Young’s modulus
and hardness of BGMSN (with Vickers indenter tip). The sintered disks were embedded into epoxy
resin and then lapped and polished. A load of 100 mN was used during the indentation process,
with a load/unload rate of 200 mN/min. Ten different sintered disks were tested, obtaining fifteen
measurements for each sintered disk. The Young’s modulus was calculated from the unloading part of
the load–depth curve according to [34]; the load–penetration depth curve was automatically recorded
for each indentation.
2.5. In Vitro Bioactivity
BGMSN sintered disks were immersed in simulated body fluid (SBF) solution to investigate the
in vitro bioactivity. The SBF solution and the volume used during the test were prepared and calculated
according to the protocol formulated by Kokubo et al. [35]. The BGMSN sintered disks were soaked
in SBF for 1, 7 and 14 days. After each soaking time, the sintered disks were carefully washed with
distilled water and then left to dry at room temperature. Then, the hydroxycarbonate apatite (HCA)
on the surface of sintered disks was investigated by means of ESEM.
2.6. Biological Tests
The biological performance was investigated using MLO-Y4 (murine long bone osteocyte Y4),
both in terms of direct and indirect cell tests.
The in vitro direct assay (NR uptake) and indirect assay (MTT) were performed according to the
International Organization for Standardization [36–38]. The NR uptake assay is based on the capability
of viable cells to bind neutral red (NR) dye. Such capability of cells to bind NR dye decreases in case of
alteration at the surface of cells or at the lysosomal membrane. Thus, through the different incorporation
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of NR dye, viable, damaged or dead cells are distinguished. On the other hand, MTT is an indirect
test named after the chemical compound 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide, which is reduced to an insoluble product (formazan) only by metabolically active cells; in fact,
only in them is it reduced by the mitochondrial succinate dehydrogenase enzyme. Subsequently,
a solubilization solution (dimethyl sulfoxide; DMSO) is used to dissolve the formazan product.
The formazan concentration into metabolically lively cells is then quantified using a spectrophotometer
(Multiscan RC by Thermolab system, Helsinki, Finland).
2.6.1. Culture of MLO-Y4 Cells
Dulbecco’s modified Eagle’s Medium (DMEM)—containing 2 mM L-Glutamine, 1 mM sodium
pyruvate, pen-streptomycin and 10% (v/v) fetal bovine serum (FBS)—was used as medium to grow
MLO-Y4 cells. The cells were incubated at 37 ± 1 ◦C, 5 ± 1% CO2/air and 90 ± 5% humidity. Then,
cells (5× 103 cells in 100 µL DMEM each well) were seeded in a multi-well culture plate. Three replicates
were prepared and tested for 24 h and 72 h.
2.6.2. Bioactive Glasses’ Eluate Preparation
BGMSN and 45S5 disks were immersed in DMEM with a ratio of 6 cm2/mL between the area of
disks and the extraction liquid volume. DMEM with non-sterile latex-free glove was used as a positive
control (CTRL+) with a ratio of 6 cm2/mL between the area of the glove and the extraction liquid
volume. On the other hand, as a negative control (CTRL-), DMEM only was used. The centrifuge
tubes were incubated at 37 ◦C for 24 h. Eluates were filtered with 0.22 µm filters (Millex-Gs 0.22 µm,
Merck Millipore, Germany) before use.
2.6.3. NR Uptake Assay at 24 h and 72 h
Cells (MLO-Y4) were cultured in multi-well plates in direct contact with BGMSN sintered disks at
37 ± 1 ◦C, 5 ± 1% CO2/air and 90 ± 5% humidity. After 24 h and 72 h, the morphology of cells was
investigated by using an optical microscope. Then, 150 µL of NR solution was added to each well after
removing DMEM (i.e., the culture medium). After 3 h of incubation at 37 ± 1 ◦C, the NR solution was
removed and 150 µL pre-warmed Dulbecco’s Phosphate Buffered Saline (DPBS) was used to eliminate
the surplus of NR solution. Then, 1500 µL of NR Desorb solution (i.e., the extraction solution) was
added to extract NR from cells; the multi-well was incubated for 20 min at room temperature. The NR
dye amount incorporated into cells was determined by measuring the absorbance (at 540 nm).
2.6.4. MTT Assay
MLO-Y4 cells were seeded in multi-wells plates in contact with 50 µL of glasses’ eluate. After 24 h
of treatment, 8 µL of tetrazolium salt (5 mg/mL in DPBS) was added to each well and incubated at
37 ◦C. 3 h after incubation, the formazan was solubilized in 100 µL of dimethyl sulfoxide (DMSO) after
removing the media. Then, after fifteen minutes of incubation at 37 ◦C, the absorbance was measured
(at 540 nm) to quantify the amount of newly synthesized formazan.
2.6.5. Statistical Analysis
Student’s t-test was employed to establish the statistical differences among groups (p < 0.05),
with a two-population comparison.
3. Results and Discussion
3.1. Thermal Behaviour
The critical temperatures of BGMSN determined by heating microscopy and DTA are reported in
Table 2.
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Table 2. Characteristic temperatures of BGMSN. * Sc = Tc-onset − Ts.
Sample Name Tg (◦C) Tc-onset (◦C) Tc (◦C) Ts (◦C) Tm (◦C) Sc (◦C) *
BGMSN 631 806 851 711 1189 95
The onset of crystallization can be observed at ~806 ◦C and an exothermic peak, corresponding to
the crystallization temperature, was visible between 810 ◦C and 900 ◦C (Figure 1). The glass transition
temperature (Tg) of BGMSN was at ~631 ◦C and its peak crystallization temperature (Tc) was 851 ◦C
(Figure 1); both temperatures are much higher compared to those of 45S5 [2,39].
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The glass transition temperature and the crystallization temperature of BGMSN are slightly
lower compared to those of Bio_MS [15] (Table 2) because the higher amount of Na2O oxide (i.e., a
network modifier) in BGMSN resulted in the decrease in the link of non-bridging oxygen bond [17,
18]. Despite this, BGMSN has one of the highest crystallization temperatures ever reported for a
bioactive glass.
Nevertheless, BGMSN has much more favorable characteristic temperatures compared to
commonly used bioactive glasses, s ch as 45S5. To this regard, it has been discovered that SrO and
MgO decrease the Tg and increase Tc of bioactive glasses [19–21]. The decrease in Tg of SrO-containing
bioactive glasses was ascribed to the ionic radius of the Sr ion, which is larger than that of the Ca ion.
The larger ionic radius of Sr ion causes an expansion of the glass network and non-bridging oxygens
(NBO) are less attracted [19]. Additionally, MgO also contributes to the decreased Tg of silicate-based
bioactive glasses, as reported in [20,21]. The effect of MgO addition coul be due to the lower average
bond strength of Si-O-Mg compared to that shown by Si-O-Si bonds. Furthermore, t e specific role of
MgO in silicate-based bioactive glasses’ network is still unclear; indeed, it has been reported to act
both as a network mo ifier [40] and as an intermediate modifier [20,41]. MgO exerts an inhibitory
effect on crystallization with a consequent increase in Tc, as reported in the literature [42,43].
A good thermal behavior of bioactive glasses can be also determined by the glass stability
parameter (GS), which is the resistance against devitrification after reheating. GS is characterized b
the difference between the peak crystallization temperature and the glass transition temperature [44].
GS can be also evaluated by using the parameter roposed by Hrubý [45] or by the Tg/Tm ratio; i.e.,
the glass transition temperature divided by the melting temperature. The larger this ratio is, the higher
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the GS is [46,47]. The Tg/Tm ratio is 0.530 for BGMSN and 0.529 for Bio_MS. Therefore, GS seems
slightly more advantageous for BGMSN than for Bio_MS.
Moreover, the sinterability parameter (Sc), which can be considered as the competition of the
sintering ability versus the crystallization tendency of glass powders [33], was higher for BGMSN
(compared to Bio_MS [15]), as reported in Table 2.
Therefore, even if the crystallization temperature is slightly higher for Bio_MS than for BGMSN,
indeed, BGMSN seems to have more favorable characteristics in terms of thermal properties. Thus,
BGMSN seems perfectly suitable for applications that require a thermal treatment.
Furthermore, Figure 2 shows the optical dilatometer analysis up to 730 ◦C. From this curve,
the CTE was evaluated for different temperature ranges and it resulted as follows: (i) range
50–300 ◦C, α = 6.50 × 10−6 ◦C−1; (ii) range 300–600 ◦C, α = 10.85 × 10−6 ◦C−1; (iii) range 600–700 ◦C,
α = 15.74 × 10−6 ◦C−1. The average value in the range 50–600◦C was 8.87 × 10−6 ◦C−1. The CTE
of BGMSN was low compared to that of 45S5, which is 15 × 10−6 ◦C−1 (in the range 200–400 ◦C),
as reported elsewhere [2,48].
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The CTE is very important for bioactive glasses, especially in the case that they have to be applied
as coatings on metallic implants [49]. In fact, due to the CTE mismatch between the coating and the
substrate, thermal residual stresses may arise [48,50–52] and this can even compromise the stability of
the coating and its adhesion to the implant [52].
It is worth noting that the CTE value of BGMSN is comparable to the CTE of Ti6Al4V
(9.5−10.5 × 10−6 ◦C−1 at 400 ◦C); thus, BGMSN could be suitable for coatings at temperatures below
the α→ β transformation of Ti [48].
3.2. Microstructural Characterization
SEM images of the surface of sintered disks (Figure 3) showed a dense microstructure, apart from
some small residual pores. Therefore, BGMSN appeared well sintered, confirming that the sintering
temperature (711 ◦C) was adequate to consolidate the samples.
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Additionally, XRD analysis confirmed the amorphous nature of BGMSN disks after the sintering
process. Indeed, the XRD diffractogram acquired on sintered disks (crushed into powder) was
characterized by the typical shape of amorphous glasses (Figure 4). The absence of any crystallization
peak in the diffractogram confirmed that the sintering temperature (711 ◦C) was appropriate and that
BGMSN has a good glass stability (GS), as already discussed above (Section 3.1).
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Figure 4. XRD diffractogram of BGMSN sintered samples.
3.3. Mechanical Characterization
The mechanical properties of BGMSN sintered disks were investigated by the micro-indentation
technique. The V kers hardn s of sintered BGMSN wa 727.4 ± 163 HV (Table 3).
Table 3. Young’s modulus and hardness, as determined by micro-indentation tests.
Young’s Modulus (GPa) Hardness (Vickers)
94 ± 13 727.4 ± 163
i t
47 V) [53]. The increase in the hardness could be due o the presence of MgO and SrO in
Materials 2020, 13, 4600 9 of 16
the composition of BGMSN, because of their high strength of metal-oxygen bond [54]. Furthermore,
the elastic modulus of BGMSN was 94 ± 13 GPa, which was higher compared to that of 45S5
(35 GPa) [2,55,56]. This confirms that the addition of MgO and SrO in its composition favors thermal
properties as well as mechanical properties. Furthermore, these results corroborate that BGMSN disks
were well sintered, as previously observed in Figure 3, and thus, the sintering temperature reported in
Table 2 is suitable for the realization of compact samples.
3.4. In Vitro Bioactivity Investigation
ESEM analyses were performed on BGMSN disks 1, 7 and 14 days after immersion in SBF.
One day after immersion in SBF, some globular precipitates of hydroxycarbonate apatite (HCA)
were visible on the disks’ surfaces (Figure 5a,b), while 7 days after immersion, the disks’ surfaces
were completely covered by precipitates of HCA with their typical morphology (i.e., cauliflower)
(Figure 5c,d). Furthermore, 14 days after immersion, the surface of the BGMSN disks was fully covered
by precipitates of HCA (Figure 5e,f). The EDS analysis reported in Figure 5g confirms the presence
of HCA on the surface of the BGMSN disks. Hydroxycarbonate apatite (HCA) mimics the mineral
component of bone and bioactive glasses bond to bone via the formation of a superficial HCA layer.
Therefore, the ability of hydroxyapatite to nucleate on the disks’ surfaces could be a preliminary
estimation of the bone-bonding ability of BGMSN. These findings ascertain the high reactivity of
BGMSN in terms of in vitro bioactivity.
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3.5. Biolog cal Investigation
Biological tests were performed both on B S and 45S5 (reference material) sintered disks.
After seeding in direct contact for 24 and 72 h, MLO-Y4 cells did not show significant changes in
cellular morphology, such as lysing, rounding, etc. (Figure 6). The MLO-Y4 cells grew on BGMSN
sintered disks, developing a morphology similar to the corresponding cells grown on 45S5 sintered
disks and CTRL- (Figure 6).
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At 24 h after direct contact, the cellular viability value of BGMSN was higher compared to the
cellular viability of 45S5, as shown in Figure 7. The cellular viability assesses the non-cytotoxicity of
BGMSN and no significant decrease in lysosomal activity imputable to cytotoxicity was observed [57].
NR uptake was also performed at 72 h after seeding; the cellular viability of BGMSN was significantly
higher (p < 0.05) compared to the cellular viability of 45S5, as reported in Figure 7.
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This could be due to the addition of SrO and MgO in the BGMSN composition with respect to
45S5; such elements are known to have beneficial biological properties, as mentioned earlier. In fact,
Sr and Mg ions are widely known to improve the replication of pre-osteoblastic cells [24,26,58] as well
as cell proliferation and angiogenesis [59,60].
Additionally, the dissolution also permits the releasing of ions such as Si, Ca and P, which are
known to positively influence cell viability and bone regeneration [61,62]. Si ions influence the
metabolic process of bone forming. Furthermore, Si is known to reduce bone resorption due to
calcium deficiency, to increase bone density [63] and to induce collagen I production and osteoblast
differentiation in human osteoblast cells [61]. On the other hand, Ca showed various roles in cells
and living systems [64], being particularly relevant in bone tissue [65] since it is one of the more
essential components of the mineralized bone matrix, together with phosphate [66]. Furthermore,
Ca ions induce the proliferation of mesenchymal precursors cells and of mature bone cells as well [67].
Finally, P ions are not only involved in various physiological process (i.e., cellular signaling, acid-base
homeostasis and in maintaining the integrity of cell membrane) but they also regulate the differentiation
and mineralization of osteoblasts and pre-osteoblasts [68,69]. These ions in vivo are fundamental in
stimulating bone regeneration, as reported in the literature, and, in fact, in vitro tests showed good
cellular viability (Figure 7) due to their synergic effect.
Furthermore, MTT assay was performed (24 h after seeding), as shown in Figure 8. The cellular
viability of BGMSN was significantly higher (p < 0.05) compared to that of 45S5. Therefore, the positive
effect pointed out by the NR test was confirmed also by the indirect test.
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In conclusion, the good cell morphology, observed in Figure 6, along with the results from NR
test a d MTT assay confirm the n n-cyt toxicity of BGMSN and its good biological perfor ance,
wi h better cell viability compared to 45S5. It can be hypothesized that the enhanced biologi al
performance of BGMSN with resp ct 45S5 depends on the presence of Sr and Mg in its composition,
which improves cell prolifera ion, angiogenesis an replicati of pre-o teoblastic cells. On the other
hand, it should be noted that the 45S5 glass underg es cryst llization during the thermal treatment
to sinter the disks; on the contrary, BGMSN remained complet ly amorphous. Therefore, it seems
reasonable to think at the reduced bi logical performance obs rved for 45S5 sa ples can be ascribed,
al o, to the glass crystallization.
Nevertheless, further tudies to deeper investigate the biological potential of BGMSN are in
progress. In vivo animal experiments are already underway, to compare the biol gical potential of
BGMSN to 45S5 and Bio_MS; the i vivo in animal model would study glass behavior (i.e., bioactive
glass diss lution i long-term implants in contact with body fl i s) and the bon regeneration process.
Furtherm re, an in ovative 3D cellular model, able to mimic the potential clinical application of a give
mat rials and used for Bio_MS [15], could be utilized to further t st BGMSN.
4. Conclusions
In this work, a new bioactive glass was designed, produced and characterized by modifying the
composition from a previ us bioactive glass (Bio_MS), whi h showed a very good combination of
properties, namely biological performance and high crystallization temperature. The composition f
BGMSN was tailored to improv bioactive glass reactivity, bioactivity in terms of rate of HCA formati n
and biological pr p rties, aintaining, a the same time, a very high crystallization temperature.
With regard to thermal behavior, BGMSN showed excellent properties, displaying a very high
crystallization temperature and a sinterability parameter (Sc) even higher than Bio_MS. Thus, BGMSN
can be conside ed among the most p omising bioactive glasses in terms of thermal behavior.
The h gh values of hardness nd Young’s modulus obtained by the micro-indentation technique
confirmed that BGMSN has adequat echanical properties.
Furt ermore, Sr and Mg ions not only favor BGMSN sinterability, igh ystalliza ion temperat re
and mechanical propertie , but such ions may als hav beneficial effects in terms of biological
properties, as widely reported in the literature. The biological performance of BGMSN was assessed
using MLO-Y4 cells. As a matter of fact, BGMSN sh wed higher cellular viability compared to that
of 45S5, which is considere as the gol standard.
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In conclusion, BGMSN showed good biological properties together with a high crystallization
temperature and a very good sinterability parameter, making it promising for orthopedic and dentistry
applications, which usually require thermal treatments. In fact, BGMSN could be favorably employed
to fabricate devices, such as sintered bodies, scaffolds and coatings.
In vivo animal models will represent future investigations to confirm the positive and encouraging
results obtained in this work.
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